Follow-The-Filings

Security · featured owners

ASMB Assembly Biosciences Inc.

Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.2%
  • $44M
  • 1 add

ASMB (Assembly Biosciences Inc.) is held in 1 featured 13F book as of 2026 Q2. Farallon Capital Management is the largest tracked holder by portfolio weight (0.20%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.2% (Farallon Capital Management) · not free-float ownership

  1. Farallon Capital Management add 0.20%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Farallon Capital Management 2026 Q2 0.20% Add +30.7% 1,604,590 $44M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 21 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K/A 2.02,9.01 Filing Doc
8-K 2.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B3 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 1.01,3.02,8.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 7 rows shown

Filed Form Detail Links
4 Period Jun 17, 2026 Filing Doc
4 Period Mar 29, 2026 · 3 forms Filing Doc
4 Period Jun 4, 2026 · 6 forms Filing Doc
4 Period Mar 29, 2026 · 2 forms Filing Doc
4 Period May 26, 2026 Filing Doc
4 Period Mar 29, 2026 · 5 forms Filing Doc
4 Period Aug 8, 2025 Filing Doc

Updated 26 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — $72.3M
Net income -$61.23M -$40.18M -$6.12M
Net margin * — — -8.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $133.79M $115.5M $254.55M
Total non-current assets * $3.04M $3.66M $3.04M
Total assets $136.82M $119.17M $257.59M
Total current liabilities $39.22M $47.8M $48.78M
Total non-current liabilities * $56.5M $38.01M $2.06M
Total equity $41.1M $33.36M $206.75M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $22.74M -$51.12M -$41.09M
Cash from investing -$69.14M $40.17M -$113.47M
Cash from financing $13.82M $29.45M $174.67M
Net change in cash -$32.58M $18.5M $20.11M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders